Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReQuest in Practice for stepped-down management of GORD
2005-000711-10Phase 4Completed
- Sponsor
- Altana Pharma
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pantoprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Altana Pharma. Primary endpoint: Performance characteristics of ReQuest in Practice. Started May 2005; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2005-000711-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000711-10.